| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-06 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |